Orano

French nuclear group Orano has inaugurated a new facility dedicated to producing lead-212, a radioactive isotope used in targeted cancer therapies such as alpha therapy. The opening marks a step into medical isotopes for the company, which is traditionally focused on nuclear fuel. Details on the site's location and production capacity have not yet been widely reported.